Helen Colquhoun

1.6k total citations · 1 hit paper
19 papers, 991 citations indexed

About

Helen Colquhoun is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Helen Colquhoun has authored 19 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 5 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Helen Colquhoun's work include Maternal Mental Health During Pregnancy and Postpartum (10 papers), Neuroendocrine regulation and behavior (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Helen Colquhoun is often cited by papers focused on Maternal Mental Health During Pregnancy and Postpartum (10 papers), Neuroendocrine regulation and behavior (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Helen Colquhoun collaborates with scholars based in United States and United Kingdom. Helen Colquhoun's co-authors include Stephen Kanes, Samantha Meltzer‐Brody, David R. Rubinow, Kristina M. Deligiannidis, Robert Riesenberg, C. Neill Epperson, Jeffrey M. Jonas, Ethan Hoffmann, Shane Raines and James Doherty and has published in prestigious journals such as The Lancet, Neurology and Annals of Neurology.

In The Last Decade

Helen Colquhoun

19 papers receiving 952 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

2018 407 citations Samantha Meltzer‐Brody, Helen Colquhoun et al. The Lancet profile →

Peers

Countries citing papers authored by Helen Colquhoun

Since Specialization

Citations

This map shows the geographic impact of Helen Colquhoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Colquhoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Colquhoun more than expected).

Fields of papers citing papers by Helen Colquhoun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Colquhoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Colquhoun. The network helps show where Helen Colquhoun may publish in the future.

Co-authorship network of co-authors of Helen Colquhoun

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Colquhoun. A scholar is included among the top collaborators of Helen Colquhoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Colquhoun. Helen Colquhoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose 2022 ·Clinical Pharmacokinetics ·(unknown), Anja Henningsson, (unknown), Ethan Hoffmann, Haihong Li, Helen Colquhoun, Kristina M. Deligiannidis	16
2	Insights on GABAergic Mechanism of PPD from Pivotal Studies of Brexanolone Injection and SAGE-217 [18E] 2020 ·Obstetrics and Gynecology ·Samantha Meltzer‐Brody, Kristina M. Deligiannidis, Helen Colquhoun, Handan Gunduz-Bruce, (unknown), Stephen Kanes	2
3	Brexanolone Injection in Postpartum Depression: Two Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trials 2019 ·Obstetrical & Gynecological Survey ·Samantha Meltzer‐Brody, Helen Colquhoun, Robert Riesenberg, C. Neill Epperson, Kristina M. Deligiannidis, David R. Rubinow, Haihong Li, Abdul J. Sankoh, Christine Clemson, (unknown), Jeffrey M. Jonas, Stephen Kanes	1
4	SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies 2019 ·Clinical Pharmacokinetics ·Ethan Hoffmann, George G. Nomikos, Inder Kaul, Shane Raines, (unknown), Amy Bullock, Abdul J. Sankoh, James Doherty, Stephen Kanes, Helen Colquhoun	45
5	Brexanolone Injection Administration to Lactating Women: Breast Milk Allopregnanolone Levels [30J] 2019 ·Obstetrics and Gynecology ·(unknown), Jeffrey Wald, (unknown), Helen Colquhoun	3
6	Brexanolone Injection in Postpartum Depression: 2 Multicenter, Double-blind, Randomized, Placebo-controlled Phase 3 Trials 2019 ·Obstetric Anesthesia Digest ·Samantha Meltzer‐Brody, Helen Colquhoun, (unknown), C. Neill Epperson, Kristina M. Deligiannidis, David R. Rubinow, (unknown), Abdul J. Sankoh, Christine Clemson, (unknown), (unknown), (unknown)	1
7	Brexanolone iv, a GABA-A receptor modulator, in postpartum depression: Pooled analysis of HAM-D sub-items 2019 ·European Neuropsychopharmacology ·Samantha Meltzer‐Brody, Helen Colquhoun, (unknown), C. Neill Epperson, Kristina M. Deligiannidis, David R. Rubinow, (unknown), Christine Clemson, Stephen Kanes	1
8	Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials breakdown → 2018 ·The Lancet ·Samantha Meltzer‐Brody, Helen Colquhoun, Robert Riesenberg, C. Neill Epperson, Kristina M. Deligiannidis, David R. Rubinow, Haihong Li, Abdul J. Sankoh, Christine Clemson, (unknown), Jeffrey M. Jonas, Stephen Kanes	407
9	S100. Efficacy and Safety of Brexanolone IV Across Phase 2/3 Studies: A First-In-Class GABAA Receptor Positive Allosteric Modulator for Postpartum Depression 2018 ·Biological Psychiatry ·Samantha Meltzer‐Brody, Stephen Kanes, Robert Riesenberg, C. Neill Epperson, Kristina M. Deligiannidis, David R. Rubinow, Haihong Li, Christine Clemson, Helen Colquhoun	2
10	850: Evaluation of breast milk concentrations following brexanolone iv administration to healthy lactating women 2018 ·American Journal of Obstetrics and Gynecology ·Ethan Hoffmann, (unknown), Helen Colquhoun	9
11	86: Brexanolone iv efficacy in postpartum depression in three pivotal trials: montgomery-åsberg depression rating scale assessment 2018 ·American Journal of Obstetrics and Gynecology ·Christine Clemson, Samantha Meltzer‐Brody, Helen Colquhoun, Robert Riesenberg, (unknown), Kristina M. Deligiannidis, David R. Rubinow, Haihong Li, Stephen Kanes	2
12	Brexanolone as adjunctive therapy in super‐refractory status epilepticus 2017 ·Annals of Neurology ·Eric S. Rosenthal, Jan Claassen, Mark S. Wainwright, Aatif M. Husain, Henrikas Vaitkevicius, Shane Raines, Ethan Hoffmann, Helen Colquhoun, James Doherty, Stephen Kanes	78
13	Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial 2017 ·The Lancet ·Stephen Kanes, Helen Colquhoun, Handan Gunduz‐Bruce, Shane Raines, Ryan Arnold, (unknown), James Doherty, C. Neill Epperson, Kristina M. Deligiannidis, Robert Riesenberg, Ethan Hoffmann, David R. Rubinow, Jeffrey M. Jonas, Steven M. Paul, Samantha Meltzer‐Brody	304
14	75. A Single-Ascending Dose Study of the Neuroactive Steroid SAGE-217 2017 ·Biological Psychiatry ·Stephen Kanes, George G. Nomikos, Michael C. Quirk, Shane Raines, James Doherty, Ethan Hoffmann, Abdul J. Sankoh, Helen Colquhoun	1
15	The pharmacokinetics of SAGE-217 in Phase 1 SAD and MAD studies (P3.008) 2017 ·Neurology ·Ethan Hoffmann, Jeffrey Wald, Shane Raines, George G. Nomikos, Helen Colquhoun, Stephen Kanes	1
16	857. A Multiple-Ascending Dose Study of the Neuroactive Steroid SAGE-217 2017 ·Biological Psychiatry ·Stephen Kanes, George G. Nomikos, Michael C. Quirk, Shane Raines, James Doherty, Ethan Hoffmann, Abdul J. Sankoh, Helen Colquhoun	1
17	Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression 2017 ·Human Psychopharmacology Clinical and Experimental ·Stephen Kanes, Helen Colquhoun, James Doherty, Shane Raines, Ethan Hoffmann, David R. Rubinow, Samantha Meltzer‐Brody	109
18	547-SSE-201 for Super-Refractory Status Epilepticus: Response and Relationship to Underlying Patient Characteristics (S14.003) 2016 ·Neurology ·Stephen Kanes, Eric S. Rosenthal, Henrikas Vaitkevicius, Jan Claassen, Mark S. Wainwright, E. Hoffman, Mollie Baird, (unknown), Helen Colquhoun	3
19	Lifarizine: A Blocker of Inactivated Voltage‐dependent Sodium Channels and Calcium Channels with Cerebral Neuroprotective Action 1995 ·CNS Drug Reviews ·C. M. Brown, (unknown), Helen Colquhoun	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact